|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.01 USD | -1.47% |
|
-10.49% | -23.91% |
| Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
| Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
Bioventus Inc.(NasdaqGS:BVS) dropped from Russell 3000E Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| -23.91% | 258M | |
| +73.12% | 12.34B | |
| -18.66% | 7.96B | |
| +15.82% | 7.16B | |
| +4.81% | 5.72B | |
| +5.99% | 5.03B | |
| +27.07% | 4.35B | |
| -21.67% | 3.99B | |
| -40.66% | 2.21B | |
| +1.49% | 2.01B |
BIOVENTUS INC. 
